Peripheral vasculopathy associated with psychostimulant treatment in children with attention-deficit/hyperactivity disorder.
Psychostimulants (methylphenidate and amphetamine salt) are the pharmacologic treatment of choice for children with attention-deficit/hyperactivity disorder. However, psychostimulants have been linked to a variety of vascular problems, including peripheral vasculopathy. This article describes four boys with attention-deficit/hyperactivity disorder who developed vasculopathy during treatment with psychostimulants.
Yu
Zheya Jenny
ZJ
Hall-Mercer MH/MR Center, Pennsylvania Hospital, University of Pennsylvania Health System, 245 South 8th Street, Philadelphia, PA 19107, USA. zheya.yu@uphs.upenn.edu
Parker-Kotler
Caroline
C
Tran
Kathleen
K
Weller
Ronald A
RA
Weller
Elizabeth B
EB
D000293:Adolescent; D000661:Amphetamine / Q000009:adverse effects*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002648:Child; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects*; D016491:Peripheral Vascular Diseases / Q000139:chemically induced*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D000661:Amphetamine